About TESA RESEARCH

At TESA Research, our mission is to accelerate progress in oncology by applying advanced machine learning to uncover meaningful and actionable patterns in multi-omic cancer data. We aim to improve the way biomarkers are discovered, validated, and integrated into precision medicine to improve patient care. Operating in stealth mode, we are quietly building breakthrough AI technologies designed to advance a new era of personalized cancer care.

Our company is built on decades of experience at the nexus of genomics, artificial intelligence, bioinformatics and software engineering. Our founding team has spearheaded the creation of industry-standard genomic analysis tools utilized in hundreds of genomic testing labs across the globe and brings a proven track record of successfully turning complex data into practical healthcare solutions.

Our proprietary platform uses neural network-based models to integrate and analyze complex multi-omic datasets — including structural genomics, transcriptomics, sequence variants, copy number variants, and epigenetic variation. TESA’s algorithms identify recurrent biological patterns across multiple genomic modalities that correlate with disease states, drug response, and prognosis.